Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2509356 | 0.94 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL3678363 | 0.67 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL27003510 | 0.67 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2 | |
| Bromide SCHEMBL2511004 | 0.65 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL2757599 | 0.60 | ADORA2B (0.38) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL18407474 | 0.59 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL19657080 | 0.57 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL12368445 | 0.57 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL2757589 | 0.56 | GAA (0.40) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL14226110 | 0.56 | ALDH1A1 (0.30) | ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8034971-B2 | Method for producing 1,2-phenylethane compound using atom transfer radical coupling reaction | NIPPON SODA CO., LTD. (JP) | 2011-10-11 | — | — | US | disclosed |
| US-20090275772-A1 | Metrod for Producing 1,2-Phenylethane Compound Using Atom Transfer Radical Coupling Reaction | NIPPON SODA CO., LTD. (JP) | 2009-11-05 | — | — | US | disclosed |
| US-7579401-B2 | Block polymer of polymethoxypolyethylene glycol monomethyl methacrylate and polystyrene; LiClO4 a lithium salt as electrolyte; living copolymerization, block polymerization; excellent thermal characteristics, physical characteristics, and ionic conductivity; secondary batteries | NIPPON SODA CO., LTD. (JP) | 2009-08-25 | — | — | US | disclosed |
| EP-1997798-A1 | METHOD FOR PRODUCING 1,2-PHENYLETHANE COMPOUND USING ATOM TRANSFER RADICAL COUPLING REACTION | Nippon Soda Co., Ltd. (JP) | 2008-12-03 | — | — | EP | disclosed |
| EP-1553117-B1 | SOLID POLYMER ELECTROLYTE | NIPPON SODA CO (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-20050256256-A1 | Block polymer of polymethoxypolyethylene glycol monomethyl methacrylate and polystyrene; LiClO4 a lithium salt as electrolyte; living copolymerization, block polymerization; excellent thermal characteristics, physical characteristics, and ionic conductivity; secondary batteries | NIPPON SODA CO., LTD (JP) | 2005-11-17 | — | — | US | disclosed |
| EP-1553117-A1 | SOLID POLYMER ELECTROLYTE | NIPPON SODA CO., LTD. (JP) | 2005-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275772-A1 | Metrod for Producing 1,2-Phenylethane Compound Using Atom Transfer Radical Coupling Reaction | ROS1, MET, MT-CO1 | ALDH1A1 74/4885SMN1; SMN2 3254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.